The ICHOM team are currently progressing site recruitment for the Coronary Artery Disease Value Community.
Heart disease is the leading cause of death for both men and women worldwide. The World Health Organisation estimates that in 2015 17.7 million deaths could be attributed to cardiovascular diseases, of which 7.4 million were due to coronary heart disease.
The lack of transparent and standardised data to enable comparisons around costs, outcomes and patient experience is a key barrier to improvement and innovation in Coronary Artery Disease (CAD) care delivery.
ICHOM offers a prospective 24 months’ project to encourage and enable a provider community made up of 15 hospitals from around the world to measure value.
The study aims to measure outcomes and costs in a standardised way in order to enable the community to understand variations in value delivery. The data collected will be used as the foundation for learning and quality improvement opportunities around both outcomes and costs.
- Measure outcomes consistently and in a standardised form via the ICHOM CAD Standard Set
- Measure the costs of outcomes delivery via Time Driven Activity Based Costing (TDABC)
- Develop a data analytics algorithm to perform risk adjustment to compare key indicators in order to enable community members to benchmark their performance with one another
- Provide individual – and confidential – reporting to participating organizations
- Support the community in utilising cost and outcomes data to improve the efficiency and efficacy of their services
- Disseminate to the wider ecosystem incl. industry and governments learnings from the programme
- Hospitals (public or private) with a cardiology clinic
- Minimum of 100 patients undergoing Percutaneous Coronary Intervention (PCI) and/or coronary artery bypass Surgery (CABG) for data collection over a 3 months’ period
- Commitment to dedicate the necessary resources available according to the study timeline described below. As a guideline, we recommend a minimum of:
- 2 FTE project manager
- FTE clinical lead
- FTE IT lead
- FTE finance lead
- Strong clinical engagement regarding outcomes measurement
- Prior experience of outcomes measurement recommended but not mandatory
- Entry fee of USD $15,000 to be secured by 30thOctober 2018
Timelines & next steps
April 2018 – Oct 2018
Application forms to completed and returned by Monday October 1st2018
October 2018 – November 2018
- Contracts and payments finalised by end of November
- Kick-off meeting will take place in October in the Netherlands
November 2018 – April 2019
- Implementation of outcomes and cost measurement will be initiated in April 2018
May 2019 – December 2019
- Data collection
- Benchmarking phase and learning collaborations
January 2020 – March 2020
- Cost and outcomes data shared with community
- Summation event
How to apply
Contact Rachel Tesfaye (Project Leader) at firstname.lastname@example.org schedule an information session and receive the application form.
The International Consortium for Health Outcomes Measurement (ICHOM) is a non-profit organization founded by three esteemed institutions (Harvard Business School, The Boston Consulting Group and Karolinska Institute) with the purpose of transforming health care systems by measuring and reporting patient outcomes in a standardized way, and by driving adoption and reporting of these measures worldwide.
Launched in 2012, ICHOM works with patients, leading providers, and registries to create a global standard for measuring results by medical condition. ICHOM supports one of the key strategic agenda items in the Value-Based Healthcare delivery framework, which aims to offer the best possible outcomes to patients for the lowest possible cost. By restructuring care-delivery around outcomes, and promoting superior outcomes with financial incentives, healthcare systems will improve quality and curb inefficiencies benefiting patients and stakeholder across the healthcare spectrum.
ICHOM takes a unique approach to defining health outcomes building patient-physicians partnerships. First, we involve patients directly in the process. All our patient representatives have been treated for the condition they are evaluating. Then, we bring together leading physicians from across the globe who specialize in treating this condition. These physicians hold diverse perspectives and are pioneers in their respective countries. Finally, the ICHOM team facilitates as physicians and patients discuss – and agree upon – the outcomes that matter most to them.
Once work is finished, ICHOM’s Standard Sets are published on its web site for all to see and benefit. ICHOM has now published 23 Standard Sets covering more than 50% of the global disease burden.
More information is available on www.ichom.org